NEUCA S.A. (WSE:NEU)

Market Cap	3.65B
Revenue (ttm)	13.34B
Net Income (ttm)	153.80M
Shares Out	4.43M
EPS (ttm)	33.88
PE Ratio	24.27
Forward PE	20.12
Dividend	16.00 (1.95%)
Ex-Dividend Date	Jul 15, 2025

Volume	884
Average Volume	1,574
Open	838.00
Previous Close	n/a
Day's Range	816.00 - 838.00
52-Week Range	636.00 - 894.00
Beta	0.46
RSI	55.09
Earnings Date	Mar 27, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.